Australia markets open in 1 hour 21 minutes

Imricor Medical Systems, Inc. (IMR.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.4750+0.0050 (+1.06%)
At close: 04:10PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 96.21M
Enterprise value 111.02M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)80.79
Price/book (mrq)4.38
Enterprise value/revenue 180.36
Enterprise value/EBITDA -5.08

Trading information

Stock price history

Beta (5Y monthly) 0.25
52-week change 361.02%
S&P500 52-week change 323.57%
52-week high 30.8350
52-week low 30.2600
50-day moving average 30.5121
200-day moving average 30.5525

Share statistics

Avg vol (3-month) 378.72k
Avg vol (10-day) 396.51k
Shares outstanding 5202.55M
Implied shares outstanding 6202.55M
Float 8129.81M
% held by insiders 126.65%
% held by institutions 16.34%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,856.57%

Management effectiveness

Return on assets (ttm)-95.73%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)615.57k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)49.80%
Gross profit (ttm)N/A
EBITDA -16.15M
Net income avi to common (ttm)-22.63M
Diluted EPS (ttm)-0.2100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)831.52k
Total cash per share (mrq)0
Total debt (mrq)10.71M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.86
Book value per share (mrq)-0.05

Cash flow statement

Operating cash flow (ttm)-12.98M
Levered free cash flow (ttm)-6.08M